Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus
A. A. Weil, K. G. Luiten, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses
M. Yousif, S. Rachida, et al.
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
H. Ma, X. Zhang, et al.
Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron
H. Liu, C. I. Kaku, et al.
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
A. L. Koen, A. Izu, et al.
